The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


400 milligram(s) Film-coated tablet

Genzyme Europe B.V.EU/1/99/123/006

Main Information

Trade NameRenagel
Active SubstancesSevelamer
Strength400 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderGenzyme Europe B.V.
Licence NumberEU/1/99/123/006

Group Information

ATC CodeV03AE02 sevelamer


Licence Issued23/04/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back